CytomX Therapeutics Inc. (CTMX) Jumped To A New High On Bristol-Myers Deal

Bristol-Myers Squibb (BMY) announced an expansion of its 2014 strategic collaboration with CytomX Therapeutics Inc. (CTMX) Monday morning. CytomX will receive $200 million upfront payment.

from RTT - Before the Bell http://ift.tt/2n94OWM
via IFTTT